Robert S. Wiesenthal
Known title: Chief Executive OfficerCIK: 0001211785
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
TripAdvisor faces rating downgrade on Experiences uncertainty. A recent analyst note downgraded TripAdvisor, arguing that the TheFork acquisition catalyst has passed while the Experiences division still needs to prove its value. This skepticism comes shortly after the company reported its Q2 2026 results. The stock currently trades near a key support level, with a high trailing P/E ratio reflecting the market's cautious stance on its future growth.
Transaction History
| SRTA | ▲ Buy | Grant | 50,234 | $0 | 7/30/2026 | View on chart |
| TRIP | ▲ Buy | Grant | 17,818 | $0 | 6/29/2026 | View on chart |
| SRTA | ▲ Buy | Grant | 40,607 | $0 | 8/29/2025 | View on chart |
| SRTA | ▲ Buy | Option Exercise | 282,470 | $51K | 8/6/2025 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 136,263 | $544K | 8/1/2025 | View on chart |
| SRTA | ▲ Buy | Grant | 246,429 | $0 | 8/1/2025 | View on chart |
| TRIP | ▲ Buy | Grant | 19,171 | $0 | 6/18/2025 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 91,031 | $346K | 6/10/2025 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 717,815 | $2.1M | 3/27/2025 | View on chart |
| SRTA | ▲ Buy | Option Exercise | 1,237,611 | $223K | 3/27/2025 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 218,479 | $682K | 3/13/2025 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 91,213 | $285K | 3/13/2025 | View on chart |
| SRTA | ▲ Buy | Grant | 394,286 | $0 | 3/13/2025 | View on chart |
| SRTA | ▲ Buy | Option Exercise | 1,237,612 | $223K | 12/19/2024 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 709,933 | $2.8M | 12/19/2024 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 91,031 | $430K | 12/11/2024 | View on chart |
| SRTA | ▼ Sell | Open Market | 2,100,000 | $6.8M | 11/14/2024 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 91,030 | $259K | 9/11/2024 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 145,571 | $428K | 6/13/2024 | View on chart |
| TRIP | ▲ Buy | Grant | 13,616 | $0 | 6/11/2024 | View on chart |
| SRTA | ▼ Sell | Open Market | 25,418 | $83K | 4/3/2024 | View on chart |
| SRTA | ▼ Sell | Open Market | 66,932 | $176K | 3/14/2024 | View on chart |
| SRTA | ▼ Sell | Open Market | 68,387 | $189K | 3/13/2024 | View on chart |
| SRTA | ▲ Buy | Grant | 45,672 | $0 | 3/8/2024 | View on chart |
| SRTA | ▼ Sell | Open Market | 17,494 | $56K | 12/15/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 41,396 | $133K | 12/14/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 37,365 | $110K | 12/13/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 37,307 | $89K | 10/6/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 28,892 | $70K | 10/5/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 34,552 | $87K | 10/4/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 81,326 | $316K | 7/6/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 63,652 | $239K | 7/6/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 62,954 | $241K | 7/6/2023 | View on chart |
| TRIP | ▲ Buy | Grant | 15,105 | $0 | 6/6/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 49,336 | $140K | 4/10/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 25,047 | $73K | 4/6/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 32,514 | $97K | 4/5/2023 | View on chart |
| SRTA | ▼ Sell | Open Market | 10,874 | $38K | 1/9/2023 | View on chart |
| SRTA | ▲ Buy | Grant | 2,365,028 | $0 | 11/9/2022 | View on chart |
| SRTA | ▼ Sell | Open Market | 9,454 | $38K | 10/6/2022 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 9,289 | $41K | 7/15/2022 | View on chart |
| TRIP | ▲ Buy | Grant | 12,800 | $0 | 6/14/2022 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 9,236 | $79K | 4/5/2022 | View on chart |
| SRTA | ▲ Buy | Grant | 268,728 | $0 | 12/16/2021 | View on chart |
| SRTA | ▼ Sell | Tax Withholding | 36,969 | $0 | 12/14/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Strata Critical Medical Releases Q2 2026 Earnings Call Transcript
Strata Critical Medical released the transcript of its Q2 2026 earnings call. The discussion covers revenue, operating expenses, and guidance for the next quarter. The release gives investors a clearer view of the company’s financial performance and outlook, which may affect trading near its support level.
Strata Critical Medical Releases Q2 2026 Earnings Call Transcript. Strata Critical Medical released the transcript of its Q2 2026 earnings call. The discussion covers revenue, operating expenses, and guidance for the next quarter. The release gives investors a clearer view of the company’s financial performance and outlook, which may affect trading near its support level.